D.E. Shaw & Co’s ASP Isotopes ASPI Stock Holding History

D.E. Shaw & Co’s Portfolio ASPI Stock Details ASPI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-54,037	Closed	-$289K	–	4528
2025 Q4	$289K	Buy	+54,037	New	+$430K	﹤0.01%	4171

Other funds holding ASPI

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ECA

Encompass Capital Advisors New York $2.81B AUM 198.36% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

RIM

Rovida Investment Management Grand Cayman, Cayman Islands $1.47B AUM 142.45% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

ETC

Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

AIC

AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return

D.E. Shaw & Co's ASPI Position: Q1 2026 in Review

D.E. Shaw & Co sold out of ASP Isotopes (ASPI) in Q1 2026, closing a stake of 54,037 shares — an estimated $289K sold.

D.E. Shaw & Co first reported a position in ASPI in Q4 2025 and held it in 1 quarter. The position peaked at $289K in Q4 2025. 177 funds tracked by Wall St. Rank hold ASPI as of Q1 2026.

D.E. Shaw & Co reported no remaining ASP Isotopes position as of Q1 2026 after selling out during the quarter.
D.E. Shaw & Co sold 54,037 ASP Isotopes shares in Q1 2026, an estimated $289K.
D.E. Shaw & Co first reported a position in ASP Isotopes in Q4 2025 and held it in 1 quarter.
D.E. Shaw & Co's ASP Isotopes position peaked at $289K in Q4 2025.
177 funds tracked by Wall St. Rank held ASP Isotopes as of Q1 2026.

Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.